Acute Non-Erosive Gastritis Associated with Irregular Dietary Habits and Psychological Stress in a Young Adult

Authors

  • Rinto Hardiarto Faculty of Medicine, Malahayati University Bandar Lampung, Indonesia Author
  • Athifah Dewi Ghinaa Yusriyyah Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Audry Rizki Hasanah Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Aufa Nabila Rahmalya Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Azzelia Zaskia Alifah Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author
  • Belinda Dewi Medical Study Program, Malahayati University Bandar Lampung, Indonesia Author

DOI:

https://doi.org/10.58524/brtl.v1i2.81

Keywords:

acute gastritis, epigastric pain, irregular dietary habits, psychological stress, proton pump inhibitor, holistic management

Abstract

Acute gastritis is a common gastrointestinal disorder characterized by sudden inflammation of the gastric mucosa, frequently associated with dietary irritation, psychological stress, and dysregulation of gastric acid secretion. Although generally considered a benign and self-limiting condition, acute gastritis may significantly impair daily functioning, particularly among young adults with irregular lifestyles. This article describes the clinical course and holistic management of acute non-erosive gastritis in a young adult, emphasizing the contribution of modifiable behavioral and psychosocial factors. A 24-year-old woman presented to a primary healthcare facility with a four-day history of epigastric burning and pressing pain, aggravated by delayed meals and the consumption of spicy and acidic foods. The patient reported irregular eating patterns and considerable academic- and work-related psychological stress. There was no history of NSAID use, alcohol consumption, smoking, or previous gastrointestinal disease. Clinical assessment was conducted through structured history taking, comprehensive physical examination, and anthropometric measurement. No laboratory or endoscopic investigations were initially performed due to the absence of alarm features. The diagnosis of acute non-erosive gastritis was established based on clinical criteria. Management consisted of an integrated approach combining pharmacological and non-pharmacological interventions. Pharmacological therapy included omeprazole 20 mg once daily to suppress gastric acid secretion and antacids administered as needed for symptomatic relief. Non-pharmacological management focused on patient and family education regarding gastric-friendly dietary patterns, regular meal timing, avoidance of trigger foods and beverages, and stress management strategies. Follow-up evaluation was planned to monitor symptom resolution and determine the need for further diagnostic investigations, including Helicobacter pylori testing or endoscopy, if symptoms persisted or worsened. Following the initiation of combined therapy and lifestyle modification, the patient demonstrated clinical improvement with reduced frequency and intensity of epigastric pain. This case underscores the importance of addressing lifestyle and psychosocial contributors in addition to pharmacological treatment in acute gastritis. The novelty of this report lies in its explicit integration of holistic clinical assessment including functional, psychological, and family-based factors within the management of acute gastritis in a young adult, highlighting a practical, patient-centered model that may reduce symptom recurrence and improve long-term outcomes in primary care settings.

References

Al, M., Beshr, M. S., Vall, M., Manuela, M., Kayal, M., Frias-gomes, C., Burisch, J., Armuzzi, A., Sawaf, B., Alom, M., Regueiro, M., Magro, F., Loftus, E. V, & Elhadi, M. (2025). Comparative efficacy of immunomodulators, biologics, and advanced therapies for steroid-refractory acute severe ulcerative colitis: A network meta-analysis and time-to-event analysis. 57, 2304–2320. https://doi.org/10.1016/j.dld.2025.10.026

Blaney, H., Zhang, W., Bandhari, P., Elfeki, M., Xie, C., Dunn, W., Wong, R., Younossi, Z., Kuo, Y., Kong, M., & Singal, A. (2025). Impact of diabetes and obesity on patient outcomes in alcohol-associated liver disease: Analysis of 3 databases. Digestive and Liver Disease, 57(12), 2390–2398. https://doi.org/10.1016/j.dld.2025.09.020

Borah, M., Biswas, R., Saha, A., & Pegu, A. K. (2023). Gastritis in Young Adults, the Evil in Disguise: A Review of Literature. Mathews Journal of Case Reports, 1854, 1–7.

Cannizzaro, R., & Spessotto, P. (2025). Gastrointestinal cancers: Therapeutic progress, diagnostic challenges, and the imperative of prevention. Digestive and Liver Disease, 57(12), 2254–2256. https://doi.org/10.1016/j.dld.2025.10.021

Ding, N., Dou, D., Zhao, L., Zhang, S., & Zhao, L. (2025). The effect of T cell-related vaccines on inflammatory bowel disease: A systematic review and meta-analysis. Digestive and Liver Disease, 57(12), 2286–2296. https://doi.org/10.1016/j.dld.2025.10.011

Fischman, M., Godny, L., Friedenberg, A., Barkan, R., White, I., Wasserberg, N., Rabinowitz, K., Avni-biron, I., Banai, H., & Snir, Y. (2025). Drug persistence of first- and advanced-line therapy for chronic inflammatory pouch disorders: A prospective cohort spanning sequential treatment lines. 57, 2370–2375. https://doi.org/10.1016/j.dld.2025.10.028

Garg, A., Moond, V., Bassi, M., Santharaman, A., Peter, S., Robert, H., Johnson, W., & Brunswick, N. (2025). Exploring the role of tofacitinib in managing chronic pouchitis: A systematic review and meta-analysis. Digestive and Liver Disease, 57(12), 2279–2285. https://doi.org/10.1016/j.dld.2025.09.007

Hoyek, C., Arsalan, S., Naqvi, A., Sahvan, O., Jamal, F., Sufyan, K., Pirozzi, A., Pathak, S., Almader-douglas, D., Borad, M. J., Wu, C., Ahn, D. H., Bin, I., & Bekaii-saab, T. (2025). Evaluating third-line therapies in refractory metastatic colorectal cancer: A systematic review and network meta-analysis. Digestive and Liver Disease, 57(12), 2297–2303. https://doi.org/10.1016/j.dld.2025.09.024

Khandelwal, V., Deshmukh, S., & Aurangabadi, K. (2024). Epidemiology and Associated Risk Factors of Gastritis in Patients at District General Hospital, Amravati. International Journal of Health Sciences and Research, 14(February), 93–100.

Mandolesi, D., Colecchia, L., Marasco, G., Bruni, A., Castellana, C., Mussomeli, E., Stanghellini, V., & Barbara, G. (2025). Epigastric pain syndrome overlaps with gastroesophageal reflux disease, while postprandial distress syndrome with esophageal disorders of gut-brain interaction. Digestive and Liver Disease, 57(12), 2362–2369. https://doi.org/10.1016/j.dld.2025.10.008

Peng, S., Song, X., Ma, X., Chen, Z., & Tian, S. (2025). Metabolic-associated fatty liver disease and Colorectal Adenoma: A Cross-Sectional Study in a Metabolically Characterized Xinjiang. 57, 2384–2389. https://doi.org/10.1016/j.dld.2025.09.010

Suralaga, C., & Usman, A. M. (2025). Unhealthy Mind, Unhealthy Gut: The Impact of Stress and Eating Patterns on Gastritis in Early Adolescents in Depok, Indonesia. Malaysian Journal of Medical Research, 9(June), 37–44.

Terrin, M., Spadaccini, M., Poletti, V., Palma, C. De, Mercurio, M., Minini, F., Spertino, M., Colombo, M., Andreozzi, M., Bonifacio, C., Capretti, G., Elisa, R., Fugazza, A., Hassan, C., Repici, A., Zerbi, A., & Carrara, S. (2025). Do all presumed BD-IPMNs require lifelong surveillance? Clinical outcomes and implications of guidelines-based discontinuation. Digestive and Liver Disease, 57, 2376–2383. https://doi.org/10.1016/j.dld.2025.10.029

Wang, J., Xu, Y., Zhang, T., Zheng, S., Luo, S., Ma, Y., Zhu, F., Zhou, C., & Gong, J. (2025). Pouch function assessment with dynamic magnetic resonance defecography after ileal pouch anal anastomosis for ulcerative colitis. 57, 2354–2361. https://doi.org/10.1016/j.dld.2025.09.027

Downloads

Published

2025-10-30